The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project

MLA

Arias-Vásquez Alejandro, et al. “The Dopamine β-Hydroxylase -1021C/T Polymorphism Is Associated with the Risk of Alzheimer’s Disease in the Epistasis Project.” BMC Medical Genetics, vol. 11, no. 1, Nov. 2010, p. 162. EBSCOhost, https://doi.org/10.1186/1471-2350-11-162.

APA

Arias-Vásquez Alejandro, Oulhaj Abderrahim, Mateo Ignacio, Kölsch Heike, Heun Reinhard, Gwilliam Rhian, Deloukas Panos, Alvarez Victoria, Coto Eliecer, Barber Rachel, Kehoe Patrick G, Brown Kristelle, Wilcock Gordon K, Lehmann Michael G, Belbin Olivia, Cortina-Borja Mario, Hammond Naomi, Warden Donald R, Combarros Onofre, … Lehmann Donald J. (2010). The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer’s disease in the Epistasis Project. BMC Medical Genetics, 11(1), 162. https://doi.org/10.1186/1471-2350-11-162

Chicago

Arias-Vásquez Alejandro, Oulhaj Abderrahim, Mateo Ignacio, Kölsch Heike, Heun Reinhard, Gwilliam Rhian, Deloukas Panos, et al. 2010. “The Dopamine β-Hydroxylase -1021C/T Polymorphism Is Associated with the Risk of Alzheimer’s Disease in the Epistasis Project.” BMC Medical Genetics 11 (1): 162. doi:10.1186/1471-2350-11-162.